These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11490570)

  • 1. Catabolism of skeletal muscle proteins and its reversal in cancer cachexia.
    Tisdale MJ
    Nestle Nutr Workshop Ser Clin Perform Programme; 2000; 4():135-43; discussion 144-6. PubMed ID: 11490570
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of skeletal muscle in cancer: biochemical mechanisms.
    Tisdale MJ
    Front Biosci; 2001 Feb; 6():D164-74. PubMed ID: 11171557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways leading to cancer cachexia.
    Tisdale MJ
    Physiology (Bethesda); 2005 Oct; 20():340-8. PubMed ID: 16174873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedicine. Protein loss in cancer cachexia.
    Tisdale MJ
    Science; 2000 Sep; 289(5488):2293-4. PubMed ID: 11041796
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia.
    Baracos VE
    Nutrition; 2000 Oct; 16(10):1015-8. PubMed ID: 11054610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional/metabolic response in older cancer patients.
    Horstman AM; Sheffield-Moore M
    Nutrition; 2015 Apr; 31(4):605-7. PubMed ID: 25770327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer anorexia and cachexia.
    Tisdale MJ
    Nutrition; 2001 May; 17(5):438-42. PubMed ID: 11377146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cachexia in cancer patients.
    Tisdale MJ
    Nat Rev Cancer; 2002 Nov; 2(11):862-71. PubMed ID: 12415256
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
    Mirza KA; Pereira SL; Voss AC; Tisdale MJ
    Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cachexia: from experimental models to patient management.
    Costelli P; Baccino FM
    Curr Opin Clin Nutr Metab Care; 2000 May; 3(3):177-81. PubMed ID: 10871232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
    Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
    Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
    Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
    Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Metabolic Dysregulation in Muscle During Cachexia.
    Hsu MY; Porporato PE; Wyart E
    Methods Mol Biol; 2019; 1928():337-352. PubMed ID: 30725463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding cachexia and excessive weight loss in cancer.
    Hemming L; Maher D
    Br J Community Nurs; 2005 Nov; 10(11):492-5. PubMed ID: 16301922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New mediators in cancer cachexia.
    Argilés JM; López-Soriano FJ
    Nestle Nutr Workshop Ser Clin Perform Programme; 2000; 4():147-62; discussion 163-5. PubMed ID: 11490571
    [No Abstract]   [Full Text] [Related]  

  • 18. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.
    Attaix D; Combaret L; Tilignac T; Taillandier D
    Mol Biol Rep; 1999 Apr; 26(1-2):77-82. PubMed ID: 10363651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
    Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
    Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling.
    Pettersen K; Andersen S; Degen S; Tadini V; Grosjean J; Hatakeyama S; Tesfahun AN; Moestue S; Kim J; Nonstad U; Romundstad PR; Skorpen F; Sørhaug S; Amundsen T; Grønberg BH; Strasser F; Stephens N; Hoem D; Molven A; Kaasa S; Fearon K; Jacobi C; Bjørkøy G
    Sci Rep; 2017 May; 7(1):2046. PubMed ID: 28515477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.